Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.39 USD
0.1%
Market Closed
Updated:
May 13, 2024
Prestige Consumer Healthcare Inc
Deferred Income Tax
|
Prestige Consumer Healthcare Inc
Deferred Income Tax Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Deferred Income Tax
$397.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
7%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Deferred Income Tax
$3.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-4%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Deferred Income Tax
$442m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
|
Pfizer Inc
NYSE:PFE
|
Deferred Income Tax
$640m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-31%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Deferred Income Tax
$922m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-17%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prestige Consumer Healthcare Inc's Deferred Income Tax?
Deferred Income Tax
397.1m
USD
397.1m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Deferred Income Tax amounts to 397.1m USD.
What is Prestige Consumer Healthcare Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
7%
7%
Over the last year, the Deferred Income Tax growth was -13%. The average annual Deferred Income Tax growth rates for Prestige Consumer Healthcare Inc have been -2% over the past three years , -2% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
